Infliximab Clinical Trials

• A Study of the Safety and Efficacy of Infliximab (Remicade) in Subjects with Fistulizing Crohn''s Disease
  ClinicalTrials.gov Identifier: NCT00207766 - Active, not recruiting
  Crohn Disease
  
• Infliximab (Remicade® (Registered Trademark)) to Treat Dermatomyositis and Polymyositis
  ClinicalTrials.gov Identifier: NCT00033891 - Active, not recruiting
  Dermatomyositis; Polymyositis
  
• A Safety and Efficacy Study of Infliximab (Remicade) in Patients with Moderate to Severe Active Crohn''s Disease
  ClinicalTrials.gov Identifier: NCT00207662 - Active, not recruiting
  Crohn Disease
  
• COMMIT (Combination Of Maintenance Methotrexate-Infliximab Trial)
  ClinicalTrials.gov Identifier: NCT00132899 - Active, not recruiting
  Crohn''s Disease
  
• Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis
  ClinicalTrials.gov Identifier: NCT00237419 - Recruiting
  Ankylosing Spondylitis
  
• Infliximab to Treat Children with Juvenile Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00029042 - Active, not recruiting
  Juvenile Rheumatoid Arthritis
  
• Beryllium Infliximab Study: Clinical Interventional Trial
  ClinicalTrials.gov Identifier: NCT00111917 - Recruiting
  Berylliosis; Beryllium Disease
  
• Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients with Unresectable Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00040885 - Active, not recruiting
  Anorexia; Cachexia; Fatigue; Non-small cell lung cancer
  
• Islet Transplantation Using Campath-1H and Infliximab Induction
  ClinicalTrials.gov Identifier: NCT00175266 - Active, not recruiting
  Type 1 Diabetes
  
• A Long Term Safety Study of Infliximab (Remicade)
  ClinicalTrials.gov Identifier: NCT00261976 - Active, not recruiting
  Psoriasis; Crohn Disease; Arthritis, Rheumatoid
  
• Infliximab in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00074074 - Active, not recruiting
  refractory anemia with excess blasts; refractory anemia with ringed sideroblasts; Refractory Anemia; de novo myelodysplastic syndromes; ...
  
• Certolizumab in Crohn's Disease Patient With Loss of Response or Intolerance to Infliximab
  ClinicalTrials.gov Identifier: NCT00308581 - Active, not recruiting
  Crohn Disease
  
• A Clinical Trial of Infliximab for Uveitis
  ClinicalTrials.gov Identifier: NCT00273390 - Active, not recruiting
  Uveitis
  
• A Long Term Safety Study of Infliximab (Remicade)
  ClinicalTrials.gov Identifier: NCT00207688 - Active, not recruiting
  Colitis, Ulcerative
  
• SONIC: Study of Biologic and Immunomodulator Naïve Patients in Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00094458 - Active, not recruiting
  Crohn's Disease
  
• Infliximab in Treating Fatigue in Postmenopausal Women Who Have Undergone Treatment for Stage 0, Stage I, or Stage II Breast Cancer
  ClinicalTrials.gov Identifier: NCT00112749 - Recruiting
  stage I breast cancer; stage II breast cancer; breast cancer in situ; Fatigue
  
• Efficacy and Safety of Infliximab Therapy in Patients with Psoriasis
  ClinicalTrials.gov Identifier: NCT00106847 - Completed
  Psoriasis
  
• Efficacy and Safety of Infliximab Therapy in Patients with Psoriasis
  ClinicalTrials.gov Identifier: NCT00106834 - Completed
  Psoriasis
  
• Infliximab in Patients with Chronic Sarcoidosis with Pulmonary Involvement
  ClinicalTrials.gov Identifier: NCT00073437 - Completed
  Sarcoidosis
  
• Induction of Remission in RA Patients at Low Disease Activity by Additional Infliximab Therapy (Study P04644AM1)
  ClinicalTrials.gov Identifier: NCT00521924 - Recruiting
  Rheumatoid Arthritis
  
• Anti Cytokine Combination Therapy With Daclizumab and Infliximab for Treatment of Steroid Refractory Acute GVHD
  ClinicalTrials.gov Identifier: NCT00574470 - Recruiting
  Graft vs Host Disease
  
• Infliximab for the Prevention of Graft-Versus-Host Disease Following Allogenic Hematopoietic Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00201799 - Active, not recruiting
  Graft-Versus-Host Disease
  
• The Effects of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis (Study P04271AM2)
  ClinicalTrials.gov Identifier: NCT00251641 - Recruiting
  Psoriasis
  
• Stop Infliximab in Patients With Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00571337 - Recruiting
  Crohn Disease
  
• Effect of Infliximab on the Efficacy of Peg-Intron/Ribavirin in Patients With Hepatitis C (Study P04257AM1)
  ClinicalTrials.gov Identifier: NCT00237484 - Recruiting
  Hepatitis C, Chronic
  
• Long-Term Effects of Infliximab in the Treatment of Moderate to Severe Psoriasis [Extension of Study P04271] (P04563)
  ClinicalTrials.gov Identifier: NCT00358670 - Recruiting
  Psoriasis
  
• Intraarticular Injection of Infliximab
  ClinicalTrials.gov Identifier: NCT00521963 - Not yet recruiting
  Arthritis
  
• A Long-Term Safety Study of Infliximab in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).
  ClinicalTrials.gov Identifier: NCT00380796 - Active, not recruiting
  COPD; Pulmonary Disease, Chronic Obstructive
  
• Use of Infliximab for the Treatment of Pemphigus Vulgaris
  ClinicalTrials.gov Identifier: NCT00283712 - Recruiting
  Pemphigus
  
• A Study of the Safety and Efficacy of Infliximab(REMICADE ) in Pediatric Subjects With Moderately to SeverelyActive Ulcerative Colitis
  ClinicalTrials.gov Identifier: NCT00336492 - Recruiting
  Ulcerative Colitis
  
• Certolizumab Pegol for Treatment of Adult Greek Population With Moderate to Severe Crohn's Disease, Who Failed on Infliximab
  ClinicalTrials.gov Identifier: NCT00307931 - Recruiting
  Crohn's Disease
  
• Gene Expression Profiling in PBMCs as a Tool for Prediction of Infliximab Responsiveness in Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00213564 - Recruiting
  Rheumatoid Arthritis
  
• Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00304954 - Recruiting
  Macular Degeneration; Neovascularization
  
• A Pilot Study of Infliximab for Treatment Resistant Major Depression
  ClinicalTrials.gov Identifier: NCT00463580 - Recruiting
  Depression; Major Depressive Disorder
  
• Infliximab to Treat Non-Infectious Scleritis
  ClinicalTrials.gov Identifier: NCT00075075 - Completed
  Scleritis
  
• OPPOSITE: Open-label, Pilot Protocol of Patients with Rheumatoid Arthritis who Switch to Infliximab after an Incomplete Response To Etanercept
  ClinicalTrials.gov Identifier: NCT00094471 - Completed
  Rheumatoid Arthritis
  
• Study of Infliximab for the Treatment of Patients with Active Ulcerative Colitis
  ClinicalTrials.gov Identifier: NCT00036439 - Completed
  Ulcerative Colitis
  
• Comparison of Adalimumab and Infliximab Treatment of Rheumatoid Arthritis.
  ClinicalTrials.gov Identifier: NCT00216177 - Recruiting
  Rheumatoid Arthritis
  
• Infliximab (Remicade) for Patients With Acute Kawasaki Disease
  ClinicalTrials.gov Identifier: NCT00271570 - Recruiting
  Kawasaki Disease
  
• Infliximab Treatment Along With Pegylated Interferon and Ribavirin in the Treatment of Hepatitis C
  ClinicalTrials.gov Identifier: NCT00512278 - Recruiting
  Hepatitis C
  
• Study of Infliximab for the Treatment of Patients with Ulcerative Colitis
  ClinicalTrials.gov Identifier: NCT00096655 - Completed
  Ulcerative Colitis
  
• Study of infliximab in combination with methotrexate for the treatment of patients with polyarticular juvenile rheumatoid arthritis
  ClinicalTrials.gov Identifier: NCT00036374 - Completed
  Juvenile Rheumatoid Arthritis
  
• Infliximab for the Treatment of Early Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00006292 - Completed
  Rheumatoid Arthritis
  
• Study of Remicade (Infliximab) in Psoriatic Arthritis
  ClinicalTrials.gov Identifier: NCT00051623 - Completed
  Psoriatic Arthritis
  
• Treatment of Refractory Diabetic Macular Edema With Infliximab
  ClinicalTrials.gov Identifier: NCT00505947 - Recruiting
  Diabetic Macular Edema; Visual Acuity; Diabetic Retinopathy
  
• Study Comparing Cyclosporine With Infliximab in Steroid-Refractory Severe Attacks of Ulcerative Colitis
  ClinicalTrials.gov Identifier: NCT00542152 - Recruiting
  Steroid-Refractory Ulcerative Colitis
  
• Efficacy & Safety of Infliximab Monotherapy Vs Combination Therapy Vs AZA Monotherapy in Ulcerative Colitis (Part 1) Maintenance Vs Intermittent Therapy for Maintaining Remission (Part 2)(Study P04807)
  ClinicalTrials.gov Identifier: NCT00537316 - Recruiting
  Ulcerative Colitis
  
• Study Evaluating the Safety and Efficacy of Infliximab in Subjects with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
  ClinicalTrials.gov Identifier: NCT00056264 - Completed
  Pulmonary Disease, Chronic Obstructive; Chronic Bronchitis; Emphysema
  
• Infliximab and Methotrexate in Ankylosing Spondylitis
  ClinicalTrials.gov Identifier: NCT00507403 - Not yet recruiting
  Ankylosing Spondylitis
  
• Infliximab to Treat Crohn's-Like Inflammatory Bowel Disease in Chronic Granulomatous Disease
  ClinicalTrials.gov Identifier: NCT00325078 - Recruiting
  Chronic Granulomatous Disease; Crohn's-Like IBD; Inflammatory Bowel Disease (IBD)
  
• Combination Methotrexate and Infliximab
  ClinicalTrials.gov Identifier: NCT00432432 - Completed
  Ankylosing Spondylitis
  
• RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides
  ClinicalTrials.gov Identifier: NCT00307593 - Completed
  Wegener's Granulomatosis; Churg-Strauss Syndrome; Microscopic Polyangiitis
  
• Treatment With TNF Blockade, Infliximab, in Patients With Myositis
  ClinicalTrials.gov Identifier: NCT00443222 - Completed
  Refractory Myositis
  
• Off Label Use of INFLIXIMAB in Adult Patients With Severe Eosinophilic Esophagitis
  ClinicalTrials.gov Identifier: NCT00523354 - Completed
  Esophagitis
  
• A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Plaque Type Psoriasis
  ClinicalTrials.gov Identifier: NCT00230529 - Completed
  Psoriasis
  
• The Effects of Infliximab in Korean Patients With Active Rheumatoid Arthritis Despite Methotrexate Treatment (Study P04280)(COMPLETED)
  ClinicalTrials.gov Identifier: NCT00202852 - Completed
  Arthritis, Rheumatoid
  
• Effects of Infliximab (Remicade) on Fat Free Mass in Patients With Moderate to Severe COPD Suffering From Cachexia
  ClinicalTrials.gov Identifier: NCT00244192 - Completed
  COPD; Cachexia
  
• Open-Label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After Incomplete Response to Etanercept
  ClinicalTrials.gov Identifier: NCT00317538 - Completed
  Rheumatoid Arthritis
  
• A Safety and Efficacy Study for Infliximab (Remicade) With Methotrexate in Patients With Early Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00236028 - Completed
  Rheumatoid Arthritis
  
• Infliximab in High Need Versus Low Need Psoriasis Patients: The IHELP Study (Study P04320)(COMPLETED)
  ClinicalTrials.gov Identifier: NCT00254982 - Completed
  Psoriasis
  
• A Comparison of Methotrexate Alone or Combined to Infliximab or to Pulse Methylprednisolone in Early Rheumatoid Arthritis: A Magnetic Resonance Imaging Study
  ClinicalTrials.gov Identifier: NCT00396747 - Completed
  Rheumatoid Arthritis
  
• Treatment of the Human Anti-TNF Monoclonal Antibody Adalimumab in Moderate to Severe Crohn's Disease With Previous Exposure to Infliximab (CHOICE)
  ClinicalTrials.gov Identifier: NCT00338650 - Completed
  Crohn's Disease
  
• Safety Study for Remicade
  ClinicalTrials.gov Identifier: NCT00036387 - Completed
  Rheumatoid Arthritis
  
• The Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) Protocol
  ClinicalTrials.gov Identifier: NCT00246064 - Completed
  Arthritis, Rheumatoid
  
• Study of Two Schedules of Infliximab Maintenance Therapy in Ankylosing Spondylitis
  ClinicalTrials.gov Identifier: NCT00439283 - Completed
  Ankylosing Spondylitis
  
• A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis.
  ClinicalTrials.gov Identifier: NCT00207701 - Completed
  Ankylosing Spondylitis
  
• GVH 022P: Study Using Anti Tumor Necrosis Factor Antibody (Infliximab) for Treatment of Acute Graft Versus Host Disease
  ClinicalTrials.gov Identifier: NCT00228839 - Completed
  Graft Vs Host Disease
  
• A Study of the Effectiveness of Low-Dose Infliximab for Treatment of Ankylosing Spondylitis (Study P04352)(COMPLETED)
  ClinicalTrials.gov Identifier: NCT00202865 - Completed
  Spondylitis, Ankylosing
  
• Infliximab Plus Methotrexate for the Treatment of Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00269867 - Completed
  Rheumatoid Arthritis
  
• Abatacept and Infliximab in Combination with Methotrexate in Subjects with Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00095147 - Completed
  Rheumatoid Arthritis
  
• Effectiveness and Safety of Enbrel® (etanercept) in Rheumatoid Arthritis Subjects who have Failed Remicade® (infliximab)
  ClinicalTrials.gov Identifier: NCT00099554 - Completed
  Rheumatoid Arthritis
  
• TNFalfa Blocking Treatment of Spondylarthropathies
  ClinicalTrials.gov Identifier: NCT00133315 - Completed
  Spondylarthropathies; Ankylosing Spondylitis; Psoriatic Arthritis
  
• Study to treat Cancer-Related Cachexia in Patients with Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00060502 - Completed
  Pancreatic Neoplasms; Cachexia
  
• Phase II Trial using Infliximab in Subjects with Giant Cell Arteritis
  ClinicalTrials.gov Identifier: NCT00076726 - Completed
  Giant Cell Arteritis; Granulomatous Arteritis